Inventor
STAVROPOULOS KATHY
US13 patents
⚠️ This page may combine multiple inventors who share the name “STAVROPOULOS KATHY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
7 patentsUS10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11884672B2Jan 30, 2024
Modulators of alpha-1 antitrypsin
VERTEX PHARMA4 citations70
US10039761B2Aug 7, 2018
Co-crystals and pharmaceutical compositions comprising the same
VERTEX PHARMA4 citations70
US10716789B2Jul 21, 2020
Co-crystals and pharmaceutical compositions comprising the same
VERTEX PHARMA3 citations68
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
US12331057B2Jun 17, 2025
Modulators of alpha-1 antitrypsin
VERTEX PHARMA1 citations60
BIOMED VALLEY DISCOVERIES INC
5 patentsUS9676746B2Jun 13, 2017
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC6 citations82
US10183927B2Jan 22, 2019
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC2 citations71
US12187698B2Jan 7, 2025
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations61
US11390600B2Jul 19, 2022
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations61
US10738027B2Aug 11, 2020
Crystalline forms of C21H22Cl2N4O2
BIOMED VALLEY DISCOVERIES INC0 citations50